Browse studies
Find your next paid study
4 recruiting studies matching your filters
A Natural History Study of Children and Adults With Olfactory Neuroblastoma
Background: Olfactory neuroblastoma (ONB) is a rare cancer. It grows from tissue in the upper part of the nose cavity, related to the sense of smell and can a…
Olfactory NeuroblastomaEsthesioneuroblastoma
Estimated
~$10 – $675
National Cancer Institute (NCI)NCT04755205
Phase 1
Phase I Trial of [212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers
Background: Some cancers have high levels of proteins called somatostatin receptors (SSTRs) on the surface of the tumors. These tumors can be in the lung, hea…
Sinonasal Neuroendocrine CarcinomaNasopharyngeal CarcinomaEsthesioneuroblastoma+7 more
Estimated
~$10 – $5,625
National Cancer Institute (NCI)NCT06479811
Phase 1
RAdiation comBined With BIspecific T-Cell Engager in DLL3 Expressing Tumors (RABBIT) Study: A Phase I/II Study of AMG757 / Tarlatamab and Concurrent Radiation Therapy in Tumors With High Prevalence of DLL3
Phase I study to examine safety of the addition of concurrent tarlatamab with standard palliative and consolidative RT regimens , with a main cohort of N=20-24…
MelanomaMedullary Thyroid CancerSinonasal Undifferentiated Carcinoma+8 more
Estimated
~$10 – $6,250
University of ArizonaNCT06814496
Phase 4
68Ga(Gallium)-DOTATATE Positron Emission Tomography (PET)/MRI in the Diagnosis and Management of Somatostatin Receptor Positive Central Nervous System CNS Tumors.
The study population consists of patients who undergo resection for somatostatin receptor-positive (SSTR-positive) CNS tumors, focusing on meningioma, and incl…
CNS TumorsMeningiomaEsthesioneuroblastoma+4 more
Estimated
~$10 – $6,250
Weill Medical College of Cornell UniversityNCT04081701